295 related articles for article (PubMed ID: 33023460)
1. MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice.
He N; Zheng X; He T; Shen G; Wang K; Hu J; Zheng M; Ding Y; Song X; Zhong J; Chen YY; Wang LL; Yueliang S
CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):298-308. PubMed ID: 33023460
[TBL] [Abstract][Full Text] [Related]
2. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
[TBL] [Abstract][Full Text] [Related]
3. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
Luo Y; Lu J; Ruan W; Guo X; Chen S
Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
[TBL] [Abstract][Full Text] [Related]
4. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
[TBL] [Abstract][Full Text] [Related]
5. Zinc promotes functional recovery after spinal cord injury by activating Nrf2/HO-1 defense pathway and inhibiting inflammation of NLRP3 in nerve cells.
Li D; Tian H; Li X; Mao L; Zhao X; Lin J; Lin S; Xu C; Liu Y; Guo Y; Mei X
Life Sci; 2020 Mar; 245():117351. PubMed ID: 31981629
[TBL] [Abstract][Full Text] [Related]
6. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NLRP3 inflammasome by MCC950 under hypoxia alleviates photoreceptor apoptosis via inducing autophagy in Müller glia.
Gao S; Li N; Lin Z; Zhong Y; Wang Y; Shen X
FASEB J; 2024 May; 38(10):e23671. PubMed ID: 38752538
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
[TBL] [Abstract][Full Text] [Related]
9. MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.
Ismael S; Nasoohi S; Ishrat T
J Neurotrauma; 2018 Jun; 35(11):1294-1303. PubMed ID: 29295651
[TBL] [Abstract][Full Text] [Related]
10. [Effects of MCC950 on nerve injury in rats with intracerebral hemorrhage].
Guo YJ; Ren J; Liu H; Li TT; Zhang S; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jan; 38(1):11-16. PubMed ID: 35634663
[No Abstract] [Full Text] [Related]
11. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.
Ward R; Li W; Abdul Y; Jackson L; Dong G; Jamil S; Filosa J; Fagan SC; Ergul A
Pharmacol Res; 2019 Apr; 142():237-250. PubMed ID: 30818045
[TBL] [Abstract][Full Text] [Related]
12. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
[TBL] [Abstract][Full Text] [Related]
13. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
[TBL] [Abstract][Full Text] [Related]
14. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
Ismael S; Zhao L; Nasoohi S; Ishrat T
Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
[TBL] [Abstract][Full Text] [Related]
17. Melatonin Attenuates Spinal Cord Injury in Mice by Activating the Nrf2/ARE Signaling Pathway to Inhibit the NLRP3 Inflammasome.
Wang H; Wang H; Huang H; Qu Z; Ma D; Dang X; Dong Q
Cells; 2022 Sep; 11(18):. PubMed ID: 36139384
[TBL] [Abstract][Full Text] [Related]
18. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
Zeng W; Wu D; Sun Y; Suo Y; Yu Q; Zeng M; Gao Q; Yu B; Jiang X; Wang Y
Sci Rep; 2021 Sep; 11(1):19305. PubMed ID: 34588488
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice.
Jiang W; Li M; He F; Zhou S; Zhu L
J Neuroinflammation; 2017 Oct; 14(1):207. PubMed ID: 29070054
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.
Li S; Lin Q; Shao X; Mou S; Gu L; Wang L; Zhang Z; Shen J; Zhou Y; Qi C; Jin H; Pang H; Ni Z
Exp Cell Res; 2019 Oct; 383(1):111488. PubMed ID: 31276670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
